| Tag | Content |
|---|
EnhancerAtlas ID | HS095-12363 |
Organism | Homo sapiens |
Tissue/cell | HMEC |
Coordinate | chr17:21171650-21172540 |
| | Number of super-enhancer constituents: 8 | ID | Coordinate | Tissue/cell |
| SE_10839 | chr17:21171246-21172318 | CD19_Primary | | SE_12406 | chr17:21171368-21172414 | CD3 | | SE_19017 | chr17:21171100-21172578 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_20528 | chr17:21170384-21172753 | CD56 | | SE_22813 | chr17:21170297-21172962 | CD8_primiary | | SE_53759 | chr17:21171287-21172361 | Spleen | | SE_58432 | chr17:21170318-21277177 | Ly1 | | SE_61419 | chr17:21170524-21296554 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I021267 | chr17 | 21170537 | 21172548 |
|
Enhancer Sequence | CTTTTCTCTT CCTGCCAGAG CTCTGTGAGG GTGGTTCTGT TACAGCCCAT TTCACAGAGG 60
TGGAAGCTGA GGGCCTGAGA GCAGAAGTTA CTTGCCTGAG TCACACATTG AGTTGGGGTG 120
GGAAACTGGT CCCTAGGCCC CCACCTTCCT CCGATCCCTA GATCAAGGGC AATGGCTTTG 180
GATCAGCAGG CCCGGCCTGG CCCCCAGTTT TGCTGTGTGA CCTTGGGTGA TTCATCTGAC 240
CTCTCTGTGC TGCTCCAGGG GTGAGGAGTT AATGAGGTGA CCCATGAGAA GGCTCCTGCC 300
CTGCTGCCCT GCACACGATC AATTCTGTCA CATATTCCTC TGTCCCTGCA GTCCCTGGAA 360
TCTCAGAATC TCCAGCAATT GCCATGGCCC CCGCCCTGCC TTGCTGCTAT TTCCCTCCAG 420
CCTCTGTATA GGTTTCTGCG TGTCTCTTCC TGTCAGGGTT TGCCACTAGC CAGGCTTTGG 480
CCCTGAGGGA TGGCATAAAC TAGTGGAATT TCAGGCAGCA AGAGGCAGAG CGACTGGGGA 540
GATATATGGG ACATTCTCAC CCCTTGTCTG GAATGTCCTT TTTCCTACAC TCCAATTGGC 600
AAACTCCTAT TCATCTTCTG AAGCCCAGGT TAAATATCGT CACTCTGAGG AGCTTTCCCC 660
CATCCTCAGC CCAGGTTGGG TCAGTCACCA CCCAGTGGCT CCCGCAGTCC CTCTGAGTGC 720
CACCATTATG TGGGTGTGGG TTTTCTTGCT CCATCGCCTG AGAGGGCCTG GGTTTTGCTC 780
ATCCCCCTAC CCATTTTAAA GAATGGGAAA CTGAGACCAG CCTGTAATCA TACAGCAAAT 840
GCAGGGCAGA GTCCTGAGGG CGAGAGTGCA GGCAAATCCC GGTCTCACCA 890
|
